1

서 론

,

35001,2)

.

0.5-2.0% ,

5-10% 13).

4)1, 2

65% ,

12-15% ,

.

,

托裏消毒飮

이상문, 홍승욱

동국대학교 한의과대학 안이비인후피부과학교실

Original Article

The Effects of Taklisodok-eum Extract on Acute Sinusitis-induced mouse

Sang-Moon Lee, Seung-Ug Hong

Dept. of Oriental Medical Ophthalmology, Otolaryngology & Dermatology, College of Oriental Medicine, Dongguk University

Background and Objectives: Sinusitis is a common disease in the otorhinolaryngology field. It is inflammatory change

of the mucous membrane which surrounds the sinus. The aim of this study was to investigate the anti-inflammatory

effects of the Taklisodok-eum (TSE) extract on the mouse model with acute sinusitis induced by S. pneumoniae.

Methods: Thirty six-week-old male BALB/c mice were divided into three groups: the normal group, the group

inoculated with S. pneumoniae which caused allergic rhinitis (control group), and the group treated with the TSE extract after it was treated the same as the control group (sample group).

Results: NF-κB activation was suppressed, and iNOS COX-2 production were inhibited by TSE in acute sinusitis.

Apoptosis was increased by TSE in acute sinusitis. The number of eosinophils in the sample group noticeably

decreased when compared to the control group. In the general morphologic change, the increase of damaged

respiratory ciliated epithelia & eosinophils’ infiltration was lessin the sample group. Goblet cells were maintained in

the sample group. MMP-9, HSP-70 and BrdU decreased in the sample group. Apocrine secretion decreased in the sample group.

Conclusion: The findings in this study show that TSE reduces acute sinusitis through its anti-inflammatory effects,

such as the inhibition of NF-κB activity.

Key Words : Taklisodok-eum, acute sinusitis, anti-inflammatory effects, NF-κB

접수：2008년 6월 4일 수정：2008년 8월 7일 채택：2008년 8월 8일

교신저자 : 홍승욱(Seung-Ug Hong)

경기도 고양시 일산동구 식사동 814번지 동국대학교 일산불교한방병원 안이비인후피부과

Tel : +82-31-961-9085, Fax : +82-31-961-9339, E-mail : heenthsu@duih.org

29 4 (2008 9 )J Korean Oriental Med 2008;29(4):01-12

29 4 (2008 9 )

2

,

,

, 5,6)

.

,

, , , 7),

.

8,9) 10-12),

9,10,12),

13),

14),

15)

,

.

S. pneumoniae

NF-κB

.

재료 및 방법

1. 실험 재료

1)

6

BALB/C 2

20g

. ,

S. pneumoniae ( ),

S. pneumoniae

( ) , 10

.

2) , MTT assay

(Taklisodok-eum,

TSE)

(Table 1). TSE 2 500

3 .

rotary evaporator 50

2.5 / 5

.

2. 실험 방법

1)

S.

pneumoniae .

ovalbumin(OVA : chicken egg

Herbal Name Scientific Name Dose(g)

金銀花 Lonicerae Flos 12

陳皮 Citri Pericarpium 12

黃 蜜水炒 Astragali Radix 8

天花粉 Trichosanthis Radix 8

防風 Ledebouriellae Radix 4

當歸酒洗 Angelicae gigantis Radix 4

川芎 Cnidii Rhizoma 4

白芷 Angelicae Dahuricae Radix 4

厚朴薑汁炒 Magnoliae Cortex 4

桔梗 Platycodi Radix 4

穿山甲炒成珠 Manitis Squama 4

角刺炒 Gleditsiae Spina 4

Total amount 72

Table 1.

S. Pneumoniae Infection

OVA/Alum ExposureOVA/Alum IP Injection Tissue obtain

Day : -14 -7 -1 1 2 3 4 5 7

Fig. 1.

(584)

1 :

3

albumin, grade V, Sigma, USA)

, PBS Al(OH)3 gel( , Sigma)

1:1 OVA 1 PBS Al(OH)3 gel

1 0.1% OVA

. , , 1,

7, 14 0.1% OVA 0.1 /20g

. 5 0.1% OVA

50

,

.

2 S.

pneumoniae 6×107 colony-forming unit

(naris) . 5

sodium pentobarbital vascular

rinse 10% (neutral buffered

formalin : NBF) .

(decalcification solution, BBC, UK) 24

5 .

Hematoxylin Eosin

(Fig. 1).

2) NF-κB

NF-κB

NF-κB

NF-κB p65(1:250,

Santa Cruz Biotec)

.

iNOS COX-2

mouse anti-mouse iNOS(1:250, Santa

Cruz Biotec) rabbit anti-mouse COX-2(1:250,

Santa Cruz Biotec)

.

NF-κB Apoptosis

in situ apoptosis detection kit(Apoptag,

Intergen, USA) TUNEL(terminal deoxynucleotid

transferase-mediated dUTP-biotin nick-end labelling)

. proteinase K

5 proteolysis equilibration buffer

20 . strength TdT

enzyme(36 TdT enzyme : 72 reaction buffer)

37 humidified chamber 1

strength stop/wash buffer 10

. Anti-digoxigenin-peroxidase 1

DAB . Hematoxylin

.

3) Eosinophil

Eosinophil

, Hinkelmann Neubauer

(Superior, Germany) .

4)

(neutral mucin)

periodic acid-schiff

reaction (PAS) stain periodic

acid 5 Schiff reagent 15

. sulfurous rinse

2 3 Hematoxylin 1

.

MMP-9

Type IV collagen matrix metallopr-

oteinase (MMP)-9 goat

anti mouse MMP-9(1:100, Santa Cruz Biotec, USA)

.

blocking serum 10% normal goat

serum (1:20, DAKO, Denmark) 12

. 1

(585)

29 4 (2008 9 )

4

mouse anti-mouse MMP-9(1:100, Santa

Cruz Biotec) 4 humidified chamber 72

, biotinylated goat anti-mouse

IgG(DAKO) 4 humidified chamber 24

link . Avidin biotin complex(DAKO) 1

0.05% 3,3’-diamin-

obenzidine(DAB) 0.01% HCl 0.05 M

tris-HCl (pH 7.4) , hema-

toxylin

.

(heat shock protein,

HSP) HSP70

rabbit anti-mouse HSP70(1:200, Santa Cruz Biotec)

.

BrdU

.

5 , 3 , 1

5-bromo-2’-deoxyuridine(BrdU,

Sigma) 50 / .

4 37 2N HCl 20

DNA-denaturation . 0.1M borate

0.01% proteinase K(DAKO)

normal goat serum 1 .

1 mouse anti-mouse BrdU (1:50,

Amersham, UK) 4 incubation chamber

72

.

Apocrine

Apocrine Phloxine-tartr-

azine . Mayer’s hematoxylin

5 phloxine 30

. tartrazine

.

5)

relative intensity

Optimas 5.2(Optima Co.,

USA) (image analysis)

. Sigmaplot 2000(Sigma, USA)

Student t-test , p <

0.05 .

실험 결과

1. NF-B 활성 억제와 염증 효소 생성 억제

1) NF-κB

(1) NF-κB

NF-κB

p65

,

ObjectiveGroup

Normal Control Sample

NF-κB p65 743±25 7204±158 2895±87*

iNOS 649±38 4104±114 1786±61*

COX-2 720±39 4393±129 1522±69*

Apoptosis 1312±59 3129±272 4137±115*

(image analysis for 200,000 particles / range of intensity : 80-120)Normal, No-treated group; Control, Sinusitis elicited group; Sample, TSE-treated group after acute sinusitis elicitation; *, P < 0.05 compared with Control. Abbreviations : NF-κB p65, nuclear factor (NF)-κB p65; iNOS, induce Nitric oxide synthase; COX-2, cyclooxygenase-2.

Table 2. κ

(586)

1 :

5

. NF-κB p65

869.6% ,

59.8%

(Table 2, Fig. 2- ).

(2)

iNOS

,

. iNOS

532.4% ,

56.8%

(Table 2, Fig. 2- ).

Prostaglandin COX-2

,

. COX-2

510.1%

, 65.4%

(Table 2, Fig. 2- ).

(3)

Apoptosis ,

. Apoptosis

138.5% ,

32.2%

(Table 2, Fig. 2- ).

Sample

Control

RM RM RM RM

RM RM RM RM

① ② ③ ④

① ② ③ ④

LP

LP

Fig. 2. κ

κ κ

EO

SIN

OPH

IL (I ul)

2500

2000

1500

1000

500

Normal ControlGROUP

Sample

Fig. 3.

(587)

29 4 (2008 9 )

6

2) Eosinophil

Eosinophil , 2310

±138 / 875±25 / 163.6%

, 1345±77 /

41.8% (Fig. 3).

3)

(1)

(Fig. 4- ).

(2)

(respiratory ciliated epithelium)

(nonciliated epithelial secretory cell)

, Eosinophil

pre-polypoid .

(Fig. 4- ).

(3)

(goblet cell) PAS

ObjectiveGroup

Normal Control Sample

MMP-9 125±60 6863±142 839±57*

HSP70 842±32 7278±104 2518±51*

BrdU 947±29 5849±125 2822±64*

(image analysis for 200,000 particles / range of intensity : 80-120)Normal, No-treated group; Control, Sinusitis elicited group; Sample, TSE-treated group after acute sinusitis elicitation; *, P < 0.05 compared with Control. Abbreviations : MMP-9, matrix metalloproteinase-9; HSP70, heat shock protein70; BrdU, 5-bromo-2'-deoxyuridine.

Table 3.

RM

①

②

③

Sample

Control

①

②

④

③

④

⑤

⑥

⑤

⑥

⑦

⑦

LP

RM

LP

RM

RM

RM

RM

RMRM

LP RM

RM

RM

Fig. 4.

(588)

1 :

7

(Fig. 4- ).

(4) MMP-9

Type IV collagen MMP-9

,

. MMP-9

5390.4% , 87.8

% (Table 3, Fig. 4- ).

(5)

HSP70

,

. HSP70

764.4%

, 65.4%

(Table 3, Fig. 4- ).

(6)

BrdU

,

. BrdU

517.6%

, 51.9%

(Table 3, Fig. 4- ).

(7) Apocrine

(hyperplasia) Apocrine

(Fig. 4- ).

고 찰

,

, , , 16)

.

30-60%17)

, ,

, X-

, CT MRI18)

.

,

.

, ,

,

, ,

, , C 19)

.

, ,

, ,

, , ,

,

, , , , 5).

, 20)

“

” .

,

, , 7).

, 8,9) 10-12)

, 9,10,12)

, 21)

, 8),

8),

9),

9),

10),

11),

11,12) .

,

(589)

29 4 (2008 9 )

8

“ ” “ ”22)

.

. 23)

“

” .

“ ” , “ ” , “ ”

, “ ”

24).

, , ,

, , , , ,

, ,

,

, , , , , , ,

, , ,

,

.

,

, , , ,

, 25,26)

, 27)

, 28,29)

, 22,30)

, 31) 32)

.

in vivo

S. pneumoniae

, NF-κB

.

.

Hilding33)

,

34,35).

36).

33-35,37).

,

Bomer 38)

38-40).

40).

S. pneumoniae

.

1986 B cell immunoglobulin κ light chain

NF-κB

p50 subunit family(p50, p52) p65 subunit family

(p65, c-Rel, RelB) (homodimer)

(heterodimer) ,

(inhibitor) IκB (Iκ

Ba, IκBβ, IκBγ, IκBε, Bcl3)

. cytokine

(590)

1 :

9

(TNF-α, IL-1), / (LPS, dsRNA),

(ROI, UV, adriamycin, )

IκB

NF-κB

NF-κB ( : 5’-GGGpuNNPyPyCC-3’)

, anti-apoptosis 41)

. IκB IκB

IKK(IKKα, β)

IκB (serine residue)

, IκB 26S proteasome

. NF-κB TNF-α, IL

-1β proinflammatory cytokine LPS

iNOS COX-2

42).

NF-κB Eosinophil

cytokine 43)

.

NF-κB p65, iNOS COX-2

.

iNOS COX-2

.

NF-κB NF-κB Antiapoptotic 44)

Apoptosis ,

Apoptosis

,

Apoptotic Eosinophil

.

Eosinophil

,

,

.

,

, .

Eosinophil

.

,

PAS

.

Type IV collagen MMP-9

HSP70

, BrdU

.

Apocrine

.

MMP-9 (undul-

ation) ,

HSP70 ,

Eosinophil

.

NF-κB

.

,

. ,

.

.

, ,

(591)

29 4 (2008 9 )

10

,

.

.

결 론

S. pneu-

moniae

NF-κB

.

1.

NF-κB p65

, iNOS

COX-2

. Apoptosis

.

2. Eosinophil

.

3.

,

, MMP-9, HSP70, BrdU

.

Apocrine .

NF-κB

,

.

참고문헌

1. Anon J.B. Report of the rhinosinusitis task force

committee meeting. Otol Head Neck Surg 1997;

117(3):S1-S48.

2. Grevers G, Klemens A. Rhinosinusitis. Current

diagnostic and therapeutic aspects. MMW Fortschr

Med. 2002;144:31-5.

3. Fagnan LJ. Acute sinusitis: a cost-effective

approach to diagnosis and treatment. Am Fam

Physician. 1998;58:1795-802,1805-6.

4. . .

. 1999;9(4): 351-9.

5. Weckx LL, Campos CA, Sakano E, Pignatari SS,

Figueiredo CR. An open multicenter study of the

use of gatifloxacin for the treatment of non-

complicated acute bacterial rhinosinusitis in

adults. Braz J Infect Dis. 2005 Apr;9(2):162-8.

Epub 2005 Aug 18.

6. Nascimento-Carvalho CM. Outpatient antibiotic

therapy as a predisposing factor for bacterial

resistance: a rational approach to airway infections.

J Pediatr (Rio J). 2006 Nov;82(5 Suppl):S146-52.

7. . . : . 2003:

570-9.

8. , , .

CT( )

. .

1999;13(2) :187-224.

9. . . .

2005.

10. . .

. 1985;6(1):93-103.

11. , . .

. 1989;10(2):180-6.

(592)

1 :

11

12. , , . ( )

12 . . 1994;15(2):

113-21.

13. , , , .

.

. 2003;17(1):1-16.

14. .

. . 2001;5:53-75.

15. .

. .

2006; 19(1):43-54.

16. . . : . 1997:281-378.

17. , . . :

. 2001:571-8.

18. . / (

). : . 2002:1017-96.

19. Scheid DC, Hamm RM. Acute bacterial rhinosin-

usitis in adults: part II. Treatment. Am Fam

Physician. 2004 Nov 1;70(9):1697-704.

20. . . :

. 1981:140,298.

21. , , , , , .

2 . . 2003;24(1):207-12.

22. , .

. . 1999;12(1):

79-98.

23. . . : . 1984:437.

24. . . : . 1993:

80.

25. . . : . 2002

:694-5.

26. . ( ). : .

1997:1588-9.

27. , , .

.

. 1994;8(1):27-37.

28. , , , , , .

.

. 2000;21(1):45-52.

29. , .

. . 2001;14(2):89-

111.

30. .

.

. 2003.

31. , , .

2 . . 2002;15

(1):301-7.

32. , , , , .

20

.

. 2002;11(1):103-10.

33. Hilding A. Experimental sinus surgery:Effects of

operative window on normal sinuses. Ann Otol.

1941;50:379-93.

34. Kumlien J, Schiratzki H. Blood flow in rabbit

sinus during experimentally induced chronic

sinusitis. Acta Otolaryngol. 1985;99:630-6.

35. Min YG, Lee YM, Lee BJ, Jung HW, Chang SO.

The effects of ostial opening on experimental

maxillary sinusitis in rabbits. Rhinology. 1993;31

:101-5.

36. , , , , , ,

, .

. Korean J Otolaryngol.

2005; 48:735-40.

37. , , , , , .

-Polylactic Acid

. . 1996;39(5):776-82.

38. Bomer K, Briclita A, Baroody F, Boonlayangoor

S, Li X, Naclerio RM. A mouse model of acute

bacterial rhinosinusitis. Arch Otolaryngol Head

Neck Surg. 1998;124:1227-32.

39. , , , , , ,

.

. Korean J Otolaryngol.

2006;49:1077-81.

40. , , , , , ,

(593)

29 4 (2008 9 )

12

, .

. Korean J Otola-

ryngol. 2006;49:52-9.

41. Baeuerle P. A., Baltimore D. NF-κB - Ten years

after. Cell. 1996;87:13-20.

42. Andrea H., Thomas k., Josef P., Konrad S.

Physiology and pathophysiology of sphingolipid

metabolism and signaling. Biochemica et Bioph-

ysica Acta. 2000;1485:63-99.

43. Takeno S, Hirakawa K, Ueda T, Furukido K,

Osada R, Yajin K. Nuclear factor-kappa B activ-

ation in the nasal polyp epithelium: relationship

to local cytokine gene expression. Laryngoscope.

2002;112(1):53-8.

44. Wu, M. X., Z. Ao, K. V. S. Prasad, R. Wu, Schlo-

ssman. IEX-IL, an apoptosis inhibitor involveed

in NF-κB-mediated cell survival. Science. 1998;

281:998-1001.

(594)